A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC Meeting Abstract
| Authors: | Chesney, J.; Wise-Draper, T.; Sarnaik, A. A.; Finckenstein, F. G.; Hari, P.; Jagasia, M.; Desai, A.; Suzuki, A.; Wu, X.; Warner, A. B. |
| Abstract Title: | A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S952 |
| Language: | English |
| ACCESSION: | WOS:000866211601154 |
| DOI: | 10.1016/j.annonc.2022.07.1009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 883TiP -- Source: Wos |
